While the second phase of COVID-19 vaccination has begun on a good note, the bid to develop other modes of vaccination are still being explored. In India, Bharat Biotech has previously sought permission from the Drugs Controller General of India (DGCI) to conduct Phase 1 and Phase 2 clinical trials of the intranasal vaccine.

While the second phase of COVID-19 vaccination has begun on a good note, the bid to develop other modes of vaccination are still being explored. In India, Bharat Biotech has previously sought permission from the Drugs Controller General of India (DGCI) to conduct Phase 1 and Phase 2 clinical trials of the intranasal vaccine.